✦ LIBER ✦

Randomized Phase II Open-Label Study of mFOLFOX6 in Combination With Linifanib or Bevacizumab for Metastatic Colorectal Cancer

✍ Scribed by O'Neil, Bert H.; Cainap, Calin; Van Cutsem, Eric; Gorbunova, Vera; Karapetis, Christos S.; Berlin, Jordan; Goldberg, Richard M.; Qin, Qin; Qian, Jiang; Ricker, Justin L.; Fischer, JuDee; McKee, Mark D.; Carlson, Dawn M.; Kim, Tae Won

Book ID: 127343646
Publisher: CIG Media Group, LP.
Year: 2014
Tongue: English
Weight: 911 KB
Volume: 13
Category: Article
ISSN: 1533-0028
DOI: 10.1016/j.clcc.2014.04.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase l/lI, Open-label, Randomised Stu

A Phase l/lI, Open-label, Randomised Study of BIBF 1120 Plus mFOLFOX6 Compared to Bevacizumab Plus mFOLFOX6 in Patients with Metastatic Colorectal Cancer

✍ E. Van Cutsem; H. Prenen; C. Guillen-Ponce; J. Bennouna; M. Di Benedetto; O. Bou 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Phase Ib Study of Drozitumab Combined Wi

Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients with Metastatic Colorectal Cancer

✍ Rocha Lima, Caio M.; Bayraktar, Soley; Flores, Aurea M.; MacIntyre, Jessica; Mon 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 223 KB

Treatment Rationale and Study Design for

Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer

✍ Bendell, Johanna C.; Ervin, Thomas J.; Gallinson, David; Singh, Jaswinder; Walla 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 608 KB

PEAK: A Randomized, Multicenter Phase II

PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer

✍ Schwartzberg, L. S.; Rivera, F.; Karthaus, M.; Fasola, G.; Canon, J.-L.; Hecht, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 520 KB

Phase I results from a two-part Phase I/

Phase I results from a two-part Phase I/II study of cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer

✍ Taroh Satoh, Kensei Yamaguchi, Narikazu Boku, Wataru Okamoto, Tomotaka Shimamura 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 204 KB

Results of a Phase II Open-Label Study o

Results of a Phase II Open-Label Study of Capecitabine in Combination with Irinotecan as First-Line Treatment for Metastatic Colorectal Cancer

✍ Thomas Cartwright; Timothy Lopez; Svetislava J. Vukelja; Carlos Encarnacion; Kri 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 485 KB